Asfar S, Zhong R, Grant D
University Hospital, London, Ontario, Canada.
Surg Clin North Am. 1994 Oct;74(5):1197-210.
After struggling for three decades, SBT is finally emerging as a clinical reality. To become the standard therapy for the treatment of end-stage intestinal failure, SBT must offer a better quality of life, fewer risks, and lower costs than home TPN. To achieve this standard, protocols must be refined to obtain lower rates of rejection and infection as well as more consistent graft function.
经过三十年的努力，小肠移植终于成为临床现实。要成为终末期肠衰竭治疗的标准疗法，小肠移植必须比家庭肠外营养提供更好的生活质量、更低的风险和成本。为达到这一标准，必须完善方案，以降低排斥反应和感染发生率，并使移植功能更稳定。
